The pharmaceuticals industry is fiercely competitive, subject to intense regulation and highly dependent upon work carried out at the R&D stage. Identification, protection and exploitation of intellectual property rights is vital to our clients’ success.
Our pharma team is highly knowledgeable about the process of development, testing and commercialisation of pharmaceutical products and their entire lifecycle.
Most of the fee-earners in our pharma team have a life-sciences degree. Each team member also has deep sectoral knowledge of the pharmaceutical and medical devices industry and so is particularly well placed to advise national and international companies on all aspects of the industry.
By drawing on the expertise of our highly respected intellectual property, corporate and dispute resolution groups, the team delivers an award-winning, high-quality and multi-disciplinary service.
For more information on pharmaceutical law click here.
News from Taylor Wessing
Briefings from Taylor Wessing
New rules will apply to most businesses selling to consumers in the EU, including to those selling online from outside the EU, from no later than 13 June 2014.
Last year — 2013 — was a considerably less eventful year for German gambling law than 2012, which saw significant reforms within the industry.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town